[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
About the Journal
Aim & Scope
Editorial Board
Indexing & Abstracting
Advertising Policy
Editorial Policies::
Peer Review Process
Section Policies
Open Access Policy
Ethical Requirements
Publication Ethics
Plagiarism Policy
Article Processing Charges (APC)
Authorship Conflicts
Intellectual Properties
Articles archive::
All Issues
Current Issue
For Authors::
Online Submmision
Instruction to Authors
Peer review process
Publication Ethics
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
Top 10 contents
Inform to friends
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Contact Us
:: Volume 29, Issue 3 (7-2017) ::
J Iran Dent Assoc 2017, 29(3): 110-118 Back to browse issues page
Correlation of EGFR Expression with Survival Rate in Patients with Oral Squamous Cell Carcinoma
Fereshteh Baghai Naini1 , Pouria Motahhary2 , Sedigheh Rahrotaban2 , Mohammad Javad Kharrazifard3 , Neda Kardouni Khozestani * 4, Mahyar Ketabi5 , Mohammad Ali Keshvad6 , Seyed Yuosef Moosavi Salehi7
1- Associate Professor, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
2- Assistant Professor, Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
3- Research Member, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
4- Assistant Professor, Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran , n_kardouni@yahoo.com
5- Oral and Maxillofacial Pathologist, Tehran, Iran
6- Student of Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
7- Periodontology Resident, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (3062 Views)
Background and Aim: This study aimed to indicate the role of epidermal growth factor (EGF) in proliferation and growth of epithelial tissue and to determine the correlation be-tween the frequency of expression of EGF receptor (EGFR) by means of immunohistochemistry with survival rate in oral squamous cell carcinoma (OSCC).
Materials and Methods: Thirty-eight cases of OSCC diagnosed by hematoxylin and eo-sin (H&E) staining were included in this prospective study, and immunohistochemistry for EGFR was applied using antibodies against EGFR. The total score of stained cells and the correlation between the total score and survival rate of patients were recorded. The data were analyzed by Kaplan-Meier, Spearman and the log rank tests using SPSS software version 20.
Results: The mean age of patients was 71.8±1.09 years. The follow up range was 25-86 months. The mean survival time for EGFR score 3 (51±9.32 months) was significantly higher than that for score 4, (28.64±4.1 months) (P=0.002) and overexpression of EGFR was correlated with poor prognosis. A significant correlation was found between the grade of tumor and EGFR scale (P=0.049, R=0.318). There was no significant correlation between EGFR overexpression and OSCC stage (P>0.05).
Conclusion: EGFR is probably an independent prognostic factor for assessment of survival rate. A correlation also exists between the grade of tumor and expression of EGFR.
Keywords: Squamous Cell Carcinoma, Epidermal Growth Factor Receptor, Epidermal Growth Fac-tor, Survival Rate
Full-Text [PDF 545 kb]   (1219 Downloads)    
Type of Study: Original | Subject: Pathology
References
1. Takakura H, Domae S, Ono T, Sasaki A. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma. Acta Med Okayama. 2017 Jun; 71(3): 219-226.
2. Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010 Apr;39(4):299-305.
3. Hasina R, Lingen MW. Angiogenesis in oral cancer. J Dent Educ. 2001 Nov;65(11):1282-90.
4. Cohen ER, Reis IM, Gomez C, Pereira L, Freiser ME, Hoosien G, et al. Immunohisto-chemistry analysis of CD44, EGFR, and p16 in oral cavity and oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2017 Aug; 157(2): 239-251.
5. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 2002 Sep 20;110(6):669-72.
6. Olapade-Olaopa EO, Moscatello DK, MacKay EH, Horsburgh T, Sandhu DP, Terry TR, et al. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer. Br J Cancer. 2000 Jan;82(1):186-94.
7. Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, et al. Expression of C-erB-2 gene in human head and neck carci-noma. Anticancer Res. 1992 Nov-Dec; 12(6B):2273-6.
8. Sarkis SA, Abdullah BH, Abdul Majeed BA, Talabani NG. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis. Head Neck Oncol. 2010 Jun 25;2:13.
9. Baschnagel AM, Tonlaar N, Eskandari M, Kumar T, Williams L, Hanna A, et al. Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas. J Oral Pathol Med. 2017 Mar;46(3):208-213.
10. Carballeira A, Ginarte M, Diniz-Freitas M, Fer-nández-Campos I, Gude F, Fraga M, et al. Immunohistochemical evaluation of EGFR expression in lip squamous cell carcinoma. Correlation with clinicopathological characteristics. Histol Histopathol. 2014 May; 29 (5):641-8.
11. Chandarana SP, Lee JS, Chanowski EJ, Sacco AG, Bradford CR, Wolf GT, et al. Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oro-pharyngeal and oral cavity cancer. Head Neck. 2013 Aug; 35(8): 1083-90.
12. Kontic M, Milovanovic J, Colovic Z, Poljak NK, Sundov Z, Sucic A, et al. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2015 Feb;272(2):401-5.
13. Sweeny L, Dean NR, Magnuson JS, Carroll WR, Helman EE, Hyde SO, et al. EGFR expression in advanced head and neck cutane-ous squamous cell carcinoma. Head Neck. 2012 May; 34(5):681-6.
14. Wu SG, Chang YL, Lin JW, Wu CT, Chen HY, Tsai MF, et al. Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction. PLoS One. 2011;6(8):e23303.
15. Yu J, Kane S, Wu J, Benedettini E, Li D, Reeves C, et al. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Clin Cancer Res. 2009 May 1;15(9): 3023-8.
16. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR. Immunohistochemical detection of p53 protein in mammary carcinoma: an im-portant new independent indicator of progno-sis? Hum Pathol. 1993 May;24(5):469-76.
17. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induc-tion of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997 Jul 11;277 (5323):225-8.
18. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head & neck. 1991 Mar-Apr; 13(2): 132-9.
19. Taoudi Benchekroun M, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila). 2010 Jul;3(7):800-9.
20. Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA. Biological significance of c-erbB family oncogenes in head and neck cancer. Can-cer Metastasis Rev. 2005 Jan;24(1):47-69.
21. Szentkúti G, Dános K, Brauswetter D, Kiszner G, Krenács T, Csákó L, et al. Correlations be-tween prognosis and regional biomarker profiles in head and neck squamous cell carcinomas. Pathol Oncol Res 2015 Jul;21(3):643-50.
22. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, et al. High EGFR expression predicts poor prognosis in patients with Oral squamous cell carcinoma of the oral cavity and oropharynxs. Oral Oncol. 2007 Feb;43(2):193-8.
23. Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, et al. Expression of cerbB2 gene in human head and neck carcino-ma. Anticancer Res. 1992 Nov-Dec; 12(6B):2273-6.
24. Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res. 2006;12(2):87-91.
25. Bagan JV, Mata-Roig M, Cortio-Gimeno J, Murillo-Cortes J, Hens-Aumente E, Poveda-Poveda-Roda R, et al. Epidermal growth factor receptor copy number in potentially malignant oral disorders and oral squamous cell carcinoma: a short communication and preliminary study. J Oral Pathol Med. 2012 Oct;41(9):662-6.
26. Ulanovski D, Stern Y, Roizman P, Shpitzer T, Popovtzer A, Feinmesser R. Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue. Oral On-col. 2004 May;40(5):532-7.
27. Bernardes VF, Gleber-Netto FO, Sousa SF, Silva TA, Aguiar MC. Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study. J Exp Clin Cancer Res. 2010 Apr 29;29:40.
28. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002 Dec 15;62 (24):7350-6.
29. Keren S, Shoude Z, Lu Z, Beibei Y. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis. Tumour Biol. 2014 Mar;35(3):2285-95.
30. Sun W, Long G, Wang J, Mei Q, Liu D, Hu G. Prognostic role of epidermal growth factor re-ceptor in nasopharyngeal carcinoma: a meta-analysis. Head Neck. 2014 Oct;36(10):1508-16.
31. Perisanidis C, Wrba F, Brandstetter A, Kornek G, Mitchell D, Seemann R, et al. Impact of epidermal growth factor receptor, mesenchy-mal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2013 Apr;51(3):234-40.
32. Monteiro L, Ricardo S, Delgado M, Garcez F, do Amaral B, Lopes C. Phosphorylated EGFR at tyrosine 1173 correlates with poor prognosis in oral squamous cell carcinomas. Oral Dis. 2014 Mar;20(2):178-85.
33. Eriksen JG, Steiniche T, Askaa J, Alsner J, Overgaard J. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):561-6.
34. Giralt J, de las Heras M, Cerezo L, Eraso A, Hermosilla E, Velez D, et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multi-center, retrospective analysis. Radiother Oncol. 2005 Feb; 74(2):101-8.
35. Yamada T, Takaga M, Shiodas S. Evaluation of EGFR in SCC of oral cavity. Oral Surg Oral Med Oral Pathol. 1992 Jan;73(1):67-70.
36. Eicheler W, Krause M, Hessel F, Zips D, Baumann M. Kinetics of EGFR expression dur-ing fractionated irradiation varies between dif-ferent human squamous cell carcinoma lines in nude mice. Radiother Oncol. 2005 Aug;76(2):151-6.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Baghai Naini F, Motahhary P, Rahrotaban S, Kharrazifard M J, Kardouni Khozestani N, Ketabi M, et al . Correlation of EGFR Expression with Survival Rate in Patients with Oral Squamous Cell Carcinoma. J Iran Dent Assoc 2017; 29 (3) :110-118
URL: http://jida.ir/article-1-1926-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 29, Issue 3 (7-2017) Back to browse issues page
Journal of Iranian Dental Association

AWT IMAGE

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645